Related Experiment Videos
Skin involvement of malignant B-cell lymphomas
The Journal of Dermatologic Surgery and Oncology
|April 1, 1984
Summary
Skin involvement in malignant B-cell lymphomas occurred in 6.17% to 9.7% of patients. This skin manifestation generally indicates a worse prognosis, except in medium-grade lymphomas.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Malignant B-cell lymphomas are a diverse group of cancers.
- Skin involvement can occur in lymphomas, potentially affecting patient outcomes.
- Understanding the frequency and prognostic impact of skin involvement is crucial for patient management.
Purpose of the Study:
- To determine the incidence of skin involvement across different grades of systemic malignant B-cell lymphomas.
- To evaluate the association between skin involvement and prognosis in these lymphomas.
Main Methods:
- Retrospective analysis of 1186 patients diagnosed with systemic malignant B-cell lymphomas.
- Categorization of lymphomas into low, medium, and high grades.
- Assessment of skin involvement at diagnosis and correlation with patient prognosis.
Main Results:
- Skin involvement was observed in 6.17% of low-grade, 9.7% of medium-grade, and 7.4% of high-grade malignant B-cell lymphomas.
- Overall, skin involvement was linked to an impaired prognosis.
- An exception was noted in medium-grade malignant lymphomas, where skin involvement did not significantly worsen the prognosis.
Conclusions:
- Skin involvement is a relevant clinical feature in systemic malignant B-cell lymphomas.
- The prognostic significance of skin involvement varies by lymphoma grade, with medium-grade lymphomas being an exception.
- Further research may elucidate the specific mechanisms behind these grade-dependent prognostic differences.